Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
Abstract Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapid evolving interstitial lung disease (ILD), driving its mortality. Specific biomarkers associated with the progression of this lung disease are highly needed. We aimed to identify specific biomarkers of SSc-ILD...
Main Authors: | Julien Guiot, Makon-Sébastien Njock, Béatrice André, Fanny Gester, Monique Henket, Dominique de Seny, Catherine Moermans, Michel G. Malaise, Renaud Louis |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-90333-0 |
Similar Items
-
A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome
by: Gilles Parzibut, et al.
Published: (2021-07-01) -
Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
by: P. Jacquerie, et al.
Published: (2021-05-01) -
Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis
by: Julien Guiot, et al.
Published: (2023-04-01) -
Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
by: Julien Guiot, et al.
Published: (2022-04-01) -
Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
by: Julien Guiot, et al.
Published: (2023-09-01)